Segue abaixo as várias fontes e referencias utilizadas para montagem do artigo “Para que serve omega 3”:
*Abdelhamid AS, Brown TJ, Brainard JS, Biswas P, Thorpe GC, Moore HJ, Deane KHO, Summerbell CD, Worthington HV, Song F, Hooper L. Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease (Review). Cochane Library. 2020. DOI: 10.1002/14651858.CD003177.pub5.
*Bang HO, Dyerberg J. Plasma lipids and lipoproteins in
Greenlandic West Coast Eskimos. Acta Medica Scandinavica
1972;192:85-94.
*Bang HO, Dyerberg J, Hjorne N. The composition of food
consumed by Greenland Eskimos. Acta Medica Scandinavica
1976;200:69-73.
*Bhatnagar D, Durrington PN. Omega-3 fatty acids: their role in the prevention and treatment of atherosclerosis related risk factors and complications. International Journal of Clinical Practice 2003;57(4):305-14.
*Bourdon JA, Bazinet TM, Arnason TT, Kimpe LE, Blais JM, White PA. Polychlorinated biphenyls (PCBs) contamination and aryl hydrocarbon receptor (AhR) agonist activity of omega-3 polyunsaturated fatty acid supplements: implications for daily intake of dioxins and PCBs. Food and Chemical Toxicology
2010;48(11):3093-7.
*British Nutrition Foundation. N-3 fatty acids and health. London: British Nutrition Foundation; 1999. Briefing paper.
*Calabresi L, Villa B, Canavesi M, Sirtori CR, James RW, Bernini F, et al. An omega-3 polyunsaturated fatty acid concentrate increases plasma high-density lipoprotein 2 cholesterol and paraoxonase levels in patients with familial combined
hyperlipidemia. Metabolism 2004;53(2):153-8.
*Campbell A, Price J, Hiatt WR. Omega-3 fatty acids for
intermittent claudication. Cochrane Database of Systematic
Reviews 2013, Issue 7. [DOI: 10.1002/14651858.CD003833.pub4]
*Chang CL, Deckelbaum RJ. Omega-3 fatty acids: mechanisms underlying “protective eCects” in atherosclerosis. Current
Opinion in Lipidology 2013;24(4):345-50. [DOI: 10.1097/
MOL.0b013e3283616364]
*Chowdhury R, Stevens S, Gorman D, Pan A, Warnakula S, Chowdhury S, et al. Association between fish consumption, long chain omega 3 fatty acids, and risk of cerebrovascular disease: systematic review and meta-analysis. BMJ
2012;345(7881):e6698.
*European Medicines Agency. EMA confirms omega-3 fatty acid medicines are not effective in preventing further heart problems after a heart attack. EMA, 2019. LINK: https://www.ema.europa.eu/en/news/ema-confirms-omega-3-fatty-acid-medicines-are-not-effective-preventing-further-heart-problems-after
*Food Standards Agency UK. Dioxins and PCBs in the UK diet: 1997 total diet study samples. Food Surveillance Information Sheet. Number 4/00; 2000. [FSIS 4/00]
*Geelen A, Brouwer IA, Zock PL, Katan MB. Antiarrhythmic eCects of n-3 fatty acids: evidence from human studies. Current Opinion
in Lipidology 2004;15:25-30.
*He Z, Yang L, Tian J, Yang K, Wu J, Yao Y. ECicacy and safety of omega-3 fatty acids for the prevention of atrial fibrillation: a meta-analysis. Canadian Journal of Cardiology
2013;29(2):196-203.
*IFFO. Global Recommendations for EPA and DHA Intake. 2015. LINK: https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=5&ved=2ahUKEwioxfvZ–XoAhXhE7kGHTKBBxYQFjAEegQIBRAB&url=http%3A%2F%2Fwww.iffo.net%2Fcn%2Fsystem%2Ffiles%2FA%25206%2520Summary%2520GOED%2520For%2520IADSA%2520only%2520english.pdf&usg=AOvVaw21RSCJmCthBQhbLTeaCLMr
*Khoueiry G, Abi Rafeh N, Sullivan E, Saiful F, JaCery Z, Kenigsberg DN, et al. Do omega-3 polyunsaturated fatty acids reduce risk of sudden cardiac death and ventricular arrhythmias? A meta-analysis of randomized trials. Heart & Lung
2013;42(4):251-6.
*Kotwal S, Jun M, Sullivan D, Perkovic V, Neal B. Omega 3 fatty acids and cardiovascular outcomes: systematic review and meta-analysis. Circulation. Cardiovascular Quality and Outcomes
2012;5(6):808-18.
*Kwak SM, Myung SK, Lee YJ, Seo HG. ECicacy of omega-3 fatty acid supplements (eicosapentaenoic acid and docosahexaenoic acid) in the secondary prevention of cardiovascular disease: a meta-analysis of randomized, double-blind, placebo-controlled
trials. Archives of Internal Medicine 2012;172(9):686-94.
*Larsson SC, Orsini N, Wolk A. Long-chain omega-3 polyunsaturated fatty acids and risk of stroke: a meta-analysis. European Journal of Epidemiology 2012;27(12):895-901.
*Levine KE, Levine MA, Weber FX, Hu Y, Perlmutter J, Grohse PM. Determination of mercury in an assortment of dietary supplements using an inexpensive combustion atomic absorption spectrometry technique. Journal of Automated Methods & Management in Chemistry 2005;2005(4):211-6.
*Liem AK, Theelen RM. Dioxins: Chemical Analysis, Exposure and Risk Assessment. Utrecht: Universiteit Utrecht, 1997. [ISBN 90
393 2012 8]
*MAFF UK. Concentrations of metals and other elements in marine fish and shellfish. Food Surveillance Information Sheet no.151; 1998. [FSIS 151]
*Mariani J, Doval HC, Nul D, Varini S, Grancelli H, Ferrante D, et al. N-3 polyunsaturated fatty acids to prevent atrial fibrillation: updated systematic review and meta-analysis of randomized controlled trials. Journal of the American Heart Association
2013;2(1):e005033.
*Rizos EC, Ntzani EE, Bika E, Kostapanos MS, Elisaf MS. Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis. JAMA 2012;308(10):1024-33.
*Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344(8934):1383-9.
*Scientific Advisory Committee on Nutrition, Committee on Toxicity. Advice on fish consumption: benefits & risks. London, United Kingdom: Her Majesty’s Stationary OCice, 2004.
*Trikalinos TA, Moorthy D, Chung M, Yu WW, Lee J, Lichtenstein AH, et al. Concordance of randomized and nonrandomized studies was unrelated to translational patterns of two nutrient-disease associations. Journal of Clinical
Epidemiology 2012;65(1):16-29.
*US Food, Drug Administration. What you need to know about mercury in fish and shellfish. www.fda.gov/food/ foodborneillnesscontaminants/metals/ucm351781.htm (accessed May 2018).
*Zhao YT, Chen Q, Sun YX, Li XB, Zhang P, Xu Y, et al. Prevention of sudden cardiac death with omega-3 fatty acids in patients with coronary heart disease: a meta-analysis of randomized controlled trials. Annals of Medicine 2009;41(4):301-10.
*Zheng T, Zhao J, Wang Y, Liu W, Wang Z, Shang Y, et al. The limited eCect of omega-3 polyunsaturated fatty acids on cardiovascular risk in patients with impaired glucose metabolism: a meta-analysis. Clinical Biochemistry
2014;47(6):369-77.
